P. B. A. Fechine

Enhancing the Safety of Nanoparticles in Medicine: Highlights of Progress and Critical Objectives

The evidence supports early integration of efficacy, mechanistic toxicology, CMC, and patient-specific risk rather than downstream safety testing alone, and indicates Harmonized characterization, clinically relevant models, long-term fate studies, and lifecycle surveillance remain central priorities for the next genera...